Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy

NCT04876326 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT04876326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04876326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Lead sponsor
Indonesia University
Phase
Not applicable
Overall status
Unknown status
Start date
October 5, 2020
Completion date
October 5, 2021
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy, multiple system atrophy, parkinson variant, parkinsonism